Cargando…

Health-Related Quality of Life in Adrenocortical Carcinoma: Development of the Disease-Specific Questionnaire ACC-QOL and Results from the PROFILES Registry

SIMPLE SUMMARY: Patients with the rare cancer adrenocortical carcinoma are exposed to many symptoms and treatment side-effects. Research on how this can affect their health-related quality of life (HRQoL) is limited, however. This article includes the first assessment of HRQoL in a population-based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steenaard, Rebecca V., Kerkhofs, Thomas M. A., Zijlstra, Myrte, Mols, Floortje, Kerstens, Michiel N., Timmers, Henry J. L. M., van Leeuwaarde, Rachel S., Dreijerink, Koen M. A., Eekhoff, Elisabeth M. W., Nieveen van Dijkum, Els J. M., Corssmit, Eleonora P. M., Kapiteijn, Ellen, Kremers, Marjolein N. T., Feelders, Richard A., Haak, Harm R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946128/ https://www.ncbi.nlm.nih.gov/pubmed/35326518 http://dx.doi.org/10.3390/cancers14061366

Ejemplares similares

Patient and Partner Perspectives on Health-Related Quality of Life in Adrenocortical Carcinoma
por: Steenaard, Rebecca V, et al.
Publicado: (2020)

Development and Internal Validation of a Multivariable Prediction Model for Adrenocortical-Carcinoma-Specific Mortality
por: Ettaieb, Madeleine H. T., et al.
Publicado: (2020)

Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing
por: Yin, Anyue, et al.
Publicado: (2020)

Health-Related Quality of Life in Adrenocortical Carcinoma
por: Steenaard, Rebecca V., et al.
Publicado: (2019)

Adrenocortical Carcinoma Treatment in the Netherlands: An Analysis From the Netherlands Cancer Registry From 2014 to 2019
por: Steenaard, Rebecca, et al.
Publicado: (2021)

Past, Present and Future of Epigenetics in Adrenocortical Carcinoma
por: Ettaieb, Madeleine, et al.
Publicado: (2020)

The Role of the IGF2 Methylation Score in Diagnosing Adrenocortical Tumors with Unclear Malignant Potential—Feasibility of Formalin-Fixed Paraffin-Embedded Tissue
por: Steenaard, Rebecca V., et al.
Publicado: (2023)

Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment
por: Libé, Rossella
Publicado: (2015)

Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients
por: Berends, Annika M. A., et al.
Publicado: (2022)

An Unusual Presentation of Adrenocortical Carcinoma (ACC): Panic Attacks and Psychosis
por: Kilani, Yassine, et al.
Publicado: (2022)

FRI192 Serum Steroid Biomarkers For The Differential Diagnosis Of Adrenocortical Carcinoma (ACC) And Adrenocortical Adenoma (ACA)
por: van Rooyen, Desmaré, et al.
Publicado: (2023)

12-Year-Old Girl Diagnosed With Li-Fraumeni Syndrome and Concomitant Adrenocortical Carcinoma (ACC)
por: Donato, Umberto M, et al.
Publicado: (2022)

Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors
por: Kerkhofs, T. M. A., et al.
Publicado: (2015)

ASO Author Reflections: Pancreatic Neuroendocrine Tumor Recurrence and Survival Predicted by Ki67
por: Nieveen van Dijkum, Els J. M.
Publicado: (2018)

Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial
por: Buitenwerf, Edward, et al.
Publicado: (2019)

Treatment of Liver Metastases from Midgut Neuroendocrine Tumours: A Systematic Review and Meta-Analysis
por: Kaçmaz, Enes, et al.
Publicado: (2019)

Whole-Exome Sequencing of Syndromic Adrenocortical Carcinoma Reveals Distinct Mutational Profile From Sporadic ACC
por: Nicolson, Norman G, et al.
Publicado: (2019)

Hemithyroidectomy versus total thyroidectomy for well differentiated T1–2 N0 thyroid cancer: systematic review and meta‐analysis
por: Rodriguez Schaap, P. M., et al.
Publicado: (2020)

The integration of mixed methods data to develop the quality of life – aged care consumers (QOL-ACC) instrument
por: Hutchinson, Claire, et al.
Publicado: (2021)

Valuing the Quality-of-Life Aged Care Consumers (QOL-ACC) Instrument for Quality Assessment and Economic Evaluation
por: Ratcliffe, Julie, et al.
Publicado: (2022)

Update on Incidence, Prevalence, Treatment and Survival of Patients with Small Bowel Neuroendocrine Neoplasms in the Netherlands
por: Kaçmaz, Enes, et al.
Publicado: (2021)

Negative illness perceptions are related to poorer health‐related quality of life among thyroid cancer survivors: Results from the PROFILES registry
por: Schoormans, Dounya, et al.
Publicado: (2020)

Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases
por: McCabe, Mark J., et al.
Publicado: (2019)

GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo
por: Chimento, Adele, et al.
Publicado: (2015)

How to Differentiate Benign from Malignant Adrenocortical Tumors?
por: Viëtor, Charlotte L., et al.
Publicado: (2021)

Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC)
por: Casaburi, Ivan, et al.
Publicado: (2015)

Identification and Verification of Immune-Related Genes Prognostic Signature Based on ssGSEA for Adrenocortical Carcinoma (ACC)
por: Yuan, Kaisheng, et al.
Publicado: (2022)

FRI199 Severe Hypertriglyceridemia And Acute Pancreatitis In A Patient With Adrenocortical Carcinoma (ACC) Taking Mitotane
por: Cortez, Briana Noel, et al.
Publicado: (2023)

The Efficacy of Mitotane in Human Primary Adrenocortical Carcinoma Cultures
por: van Koetsveld, Peter M, et al.
Publicado: (2019)

Assessing the construct validity of the Quality-of-Life-Aged Care Consumers (QOL-ACC): an aged care-specific quality-of-life measure
por: Khadka, J., et al.
Publicado: (2022)

Venous thromboembolism in patients with adrenocortical carcinoma after surgery
por: Durmuşoğlu, Jülide, et al.
Publicado: (2020)

Bilaterality, not multifocality, is an independent risk factor for recurrence in low-risk papillary thyroid cancer
por: Rodriguez Schaap, Pedro Manuel, et al.
Publicado: (2023)

A pain in the ACC
por: Frankland, Paul W, et al.
Publicado: (2005)

An Adrenal Mass and Increased Catecholamines: Monoamine Oxidase or Pheochromocytoma Effect?
por: Bosscher, Marianne R. F., et al.
Publicado: (2015)

Type D personality in the general population: a systematic review of health status, mechanisms of disease, and work-related problems
por: Mols, Floortje, et al.
Publicado: (2010)

Adrenocortical Carcinoma (ACC) Cells Rewire Their Metabolism to Overcome Curcumin Antitumoral Effects Opening a Window of Opportunity to Improve Treatment
por: Nocito, Marta Claudia, et al.
Publicado: (2023)

Health‐related quality of life and treatment effects in patients with well‐differentiated gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta‐analysis
por: Ronde, Elsa M., et al.
Publicado: (2021)

The role of mTOR pathway as target for treatment in adrenocortical cancer
por: De Martino, Maria Cristina, et al.
Publicado: (2019)

Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas
por: Hackeng, Wenzel M., et al.
Publicado: (2020)

Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC
por: Doghman-Bouguerra, Mabrouka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m8epvtsbu0khr7ljjn7q9i9odb